Data and Code for "Patents, Innovation, and Competition in Pharmaceuticals: The Hatch- Waxman Act After Forty Years"

Principal Investigator(s):  View help for Principal Investigator(s) C. Scott Hemphill, NYU School of Law; Bhaven Sampat, Arizona State University

Version:  View help for Version V1

Name File Type Size Last Modified
  code 04/18/2025 01:52:PM
  data 04/18/2025 01:52:PM
  output 04/18/2025 01:52:PM
README-26APRIL2025.pdf application/pdf 272.1 KB 04/26/2025 08:09:AM

Project Citation: 

Hemphill, C. Scott, and Sampat, Bhaven. Data and Code for “Patents, Innovation, and Competition in Pharmaceuticals: The Hatch- Waxman Act After Forty Years.” Nashville, TN: American Economic Association [publisher], 2025. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2025-05-05. https://doi.org/10.3886/E218443V1

Project Description

Summary:  View help for Summary The central issue in pharmaceuticals, as a matter of economic inquiry and regulatory design, is how to balance the dynamic benefits of new drugs against the static benefits of low prices for existing drugs. In the United States, that balance is set by the Drug Price Competition and Patent Term Restoration Act of 1984, commonly known as the Hatch-Waxman Act. The 40th anniversary of the Act presents an opportunity to assess the Act’s successes and failures thus far. We provide evidence on the effects of the Act's patent listing, challenge, and restoration provisions. 
Funding Sources:  View help for Funding Sources National Institute for Health Care Management

Scope of Project

Subject Terms:  View help for Subject Terms pharmaceuticals; patents; innovation; competition
JEL Classification:  View help for JEL Classification
      L65 Chemicals; Rubber; Drugs; Biotechnology; Plastics
      O30 Innovation; Research and Development; Technological Change; Intellectual Property Rights: General


Related Publications

Download this project

Published Versions

V1 [2025-05-05]

Export Metadata

Dublin Core

DDI 2.5

Report a Problem

Found a serious problem with the data, such as disclosure risk or copyrighted content? Let us know.

This material is distributed exactly as received from the data depositor. As of April 2026, depositors are required to submit study materials in accessible formats. ICPSR has not reviewed, checked, or processed this material. For additional information about the study, please contact the investigator(s) directly. If you have questions about the accessibility of materials distributed by ICPSR or require further assistance, please visit ICPSR's Accessibility Center.